Clinical Trials Browser

Phase 2/3 × Tyrosine Kinase Inhibitors × Clear all

NCT03256981 2023-12-26

HALT

Phase 2/3 Unknown

NSCLC

NCT02794337 2022-04-27

TACE-SBRT

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT03624530 2018-08-10

Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplants

Phase 2/3 Unknown

Neoplasm, Residual